CompletedNot Applicable

Effect of Saccharomyces Cerevisiae on the Improvement of Gastro-intestinal Disorders Associated to IBS With C Phenotype

France456 participantsStarted 2017-03-20

Plain-language summary

The main objective is to assess the effect of an 8-week daily supplementation with IbSium® (probiotic yeast Saccharomyces cerevisiae CNCM I-3856) on the improvement gastro-intestinal disorders associated to the type C IBS (constipation predominant).

Who can participate

Age range18 Years – 75 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Related to defecation,
✓. Associated with a change in stool frequency,
✓. Associated with a change of the stools appearance.

What they're measuring

Abdominal pain/discomfort score rated with Likert scale (ranging from 0 to 7)

Timeframe: Week 5 to Week 8

Trial details

NCT IDNCT03150212

SponsorLesaffre International

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2019-05-09

View on ClinicalTrials.gov More Constipation-predominant Irritable Bowel Syndrome trials